Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study

被引:0
|
作者
Tomoya Shukuri
Kentaro Nakai
Shigeru Tanaka
Shunsuke Yamada
Masanori Tokumoto
Kazuhiko Tsuruya
Toshiaki Nakano
Takanari Kitazono
机构
[1] Japanese Red Cross Fukuoka Hospital,Departure of Nephrology
[2] Kyushu University,Department of Medicine and Clinical Science, Graduate School of Medical Sciences
[3] Nara Medical University,Department of Nephrology
来源
Clinical and Experimental Nephrology | 2023年 / 27卷
关键词
angiotensin II receptor blockers; Bone fracture; Chronic kidney disease; Fukuoka Kidney disease Registry Study;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:919 / 927
页数:8
相关论文
共 50 条
  • [41] Fracture risk assessment in patients with chronic kidney disease
    S. A. Jamal
    S. L. West
    P. D. Miller
    Osteoporosis International, 2012, 23 : 1191 - 1198
  • [42] Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report
    Venuthurupalli, Sree K.
    Healy, Helen
    Fassett, Robert
    Cameron, Anne
    Wang, Zaimin
    Hoy, Wendy E.
    NEPHROLOGY, 2019, 24 (12) : 1257 - 1264
  • [43] Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study
    Manotham, K.
    Ongvilawan, B.
    Urusopone, P.
    Chetsurakarn, S.
    Tanamai, J.
    Limkuansuwan, P.
    Tungsanga, K.
    Eiam-Ong, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (04) : e33 - e37
  • [44] Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease
    Soares, Abel Esteves
    Maes, Michael
    Godeny, Paula
    Matsumoto, Andressa Keiko
    Barbosa, Decio Sabbatini
    da Silva, Taysa Antonia F.
    Souza, Flvio Henrique M. O.
    Alvares Delfino, Vinicius Daher
    LIFE SCIENCES, 2017, 191 : 175 - 179
  • [45] Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney disease
    Ikeda, Masato
    Nakao, Masatsugu
    Hirano, Keita
    Yokoyama, Keitaro
    Yokoo, Takashi
    Joki, Nobuhiko
    Ando, Ryoichi
    Shinoda, Toshio
    Inaguma, Daijo
    Yamaka, Toshihiko
    Komatsu, Yasuhiro
    Koiwa, Fumihiko
    Sakaguchi, Toshifumi
    Negi, Shigeo
    Shigematsu, Takashi
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (04) : 1175 - 1184
  • [46] Trabecular bone score in patients with chronic kidney disease
    Rampersad, C.
    Whitlock, R. H.
    Leslie, W. D.
    Rigatto, C.
    Komenda, L. P.
    Bohm, C.
    Hans, D.
    Tangri, N.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (10) : 1905 - 1912
  • [47] Trabecular bone score in patients with chronic kidney disease
    C. Rampersad
    R. H. Whitlock
    W. D. Leslie
    C. Rigatto
    P. Komenda
    C. Bohm
    D. Hans
    N. Tangri
    Osteoporosis International, 2020, 31 : 1905 - 1912
  • [48] Bone loss in diabetic patients with chronic kidney disease
    Rigalleau, V.
    Lasseur, C.
    Raffaitin, C.
    Perlemoine, C.
    Barthe, N.
    Chauveau, P.
    Aparicio, M.
    Combe, C.
    Gin, H.
    DIABETIC MEDICINE, 2007, 24 (01) : 91 - 93
  • [49] Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
    Ahmed, Aimun
    Jorna, Tom
    Bhandari, Sunil
    NEPHRON, 2016, 133 (03) : 147 - 158
  • [50] Underprescription of Renin-Angiotensin System Blockers in Moderate to Severe Chronic Kidney Disease
    Shirazian, Shayan
    Grant, Candace D.
    Mujeeb, Shanza
    Sharif, Sairah
    Kumari, Pooja
    Bhagat, Milind
    Mattana, Joseph
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (06) : 510 - 515